Translational Haematology
Our Translational Hematology group was created with the aim of generating knowledge in the field of hematology and collaborating with other groups for the implementation of projects. Our activity is based on a broad portfolio of clinical trials, basic research projects and registry studies. The area of knowledge in which we focus is the study of the immune system and its relationship with oncohematological diseases and their infectious complications, cell therapy, study of the adverse effects of drugs and optimization in obtaining and using blood components in Transfusion Therapy.
Search for publications
Only original articles, editorials, guidelines.
-
Chatzikonstantinou T, Mikhaleva M, Brieghel C, Papangelou C, Minga E, Arrais-Rodrigues C, Dimou-Besikli S Dr, Cerutti A, Doubek M, Enggaard L, Espinet B, Ferrer-Lores B, Garcia Vela JA, Gentile M, Gimeno Vazquez E, Gutwein O, Herishanu Y, Jablonowska-Babij P, Jaksic O, Josefsson P, Kalicinska E, Kislova M, Lista E, Kotsianidis I, Marquet J, Martino EA, McAuley CP, Mela-Osorio MJ, Moia R, Mosquera Rubal C, Nikitin EA, Pavlovsky MA, Pfister V, Savas EM, Scarfò L, Sever M, Shvidel L, Simkovic M, Stavroyianni N, Talimtzi P, Tranidou A, Visentin A, Vrachiolias G, Wasik-Szczepanek E, Wróbel T, Yagci M, Cellini A, Chatzidimitriou A, Gaidano G, Anderson MA, Davids MS, Brown JR, Niemann CU, Stamatopoulos K, Ghia P, Ahn IE, Koren-Michowitz M.
Central Nervous System Involvement in CLL: An International Retrospective Study by ERIC, the European Research Initiative on CLL.
Blood Advances . 10(2): 428-438.
-
Pérez-Lamas L, Manzanares M, Hernández Boluda JC, Casado Montero LF, Gómez Casares MT, Ayala R, Xicoy B, Ferrer Marin F, Ortí G, De Paz Arias R, Osorio Prendes S, Perez Lopez R, Mora E, Ruiz Nuño C, Jimenez Velasco A, Boqué C, Sierra Pacho M, Martinez Lopez J, Carreño-Tarragona G, Coiras M, Garcia-Gutierrez V.
One-year consolidation with Ponatinib 15 mg in chronic myeloid leukaemia on deep molecular response with Imatinib.
ANNALS OF HEMATOLOGY . 105(2): 40-40.
-
García de la Torre I, García-Hoz C, Martin-Moro F, Fernández-Velasco JI, Velázquez-Kennedy K, Rodríguez-Martín E, Luna De Abia A, Roldán E, Moreno Jiménez G, López-Jiménez J, Villar LM, Pariente-Rodríguez R.
Apheresis CD8(+)CCR7(+)CD45RA(-) T-Cells as a Novel Biomarker Associated with CAR T-Cell Kinetics and Clinical Outcome.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 27(2): .
-
Coucelo M, Sargas C, Ayala R, Larráyoz MJ, Chillón MC, Soria E, Bilbao C, de la Torre EP, Amorim ML, Mirales A, Cionfrini A, Simões AT, Oliveira AC, Rodríguez-Veiga R, Lloret-Madrid P, Mendizábal Y, Botella C, Bernal T, Bergua J, Algarra L, Tormo M, Sarmento-Ribeiro AB, Trigo F, Cortesão E, Martínez-Sánchez P, Serrano J, Alonso-Domínguez JM, García R, Amigo ML, Herrera-Puente P, Sayas MJ, Abuín A, Martínez-López J, Calasanz MJ, García-Sanz R, Gutiérrez N, Pérez-Simón JA, Gómez Casares MT, Sánchez-Garcia J, Montesinos P, Barragán E.
Interlaboratory cross validation of acute myeloid leukemia fusion genes and mutational targets detected by PCR: Performance of PETHEMA central laboratories.
LEUKEMIA RESEARCH . 160: 108149-108149.
-
Montesinos P, Rodríguez-Veiga R, Bergua JM, Algarra Algarra JL, Botella C, Rodríguez-Arbolí E, Bernal T, Tormo M, Calbacho M, Salamero O, Serrano J, Noriega V, López-López JA, Vives S, López-Lorenzo JL, Colorado M, Vidriales MB, Boyero RG, Olave MT, Herrera P, Arce O, Barrios M, Sayas MJ, Polo M, Gómez-Roncero MI, Barragán E, Ayala R, Chillón C, Calasanz MJ, Paiva B, Boluda B, Casas-Avilés I, Lloret P, Sánchez MJ, Rodríguez-Medina C, Cuevas L, Raposo-Puglia JÁ, Mateos MC, Olivares M, Martínez-Chamorro C, Alonso N, Suárez S, Sánchez-Vadillo I, Rodríguez MS, González BJ, Martínez-Francés A, Cuello R, Fernández A, Martínez-Cuadrón D, Labrador J.
Quizartinib for Newly Diagnosed FLT3-ITD-Negative Acute Myeloid Leukemia: The Randomized, Double-Blind, Placebo-Controlled, Phase 2 QUIWI Study.
JOURNAL OF CLINICAL ONCOLOGY . 44(1): 42-53.
-
Domínguez-Ruiz M, Chico JL, López-Marín L, Stanescu S, Crujeiras P, Rodrigues D, Heras-Alonso ML, Torremocha R, Meijón-Ortigueira MDM, Muñoz-Díez P, Lanza VF, Colón C, Villarrubia J, Belanger A, Castillo FJD.
Abnormal Splicing of GALC Transcripts Underlies Unusual Cases of Krabbe Disease
Biomedicines . 13(12): .
-
Cedena MT, Puig N, Paiva B, de la Puerta Rueda JE, Pérez-Montaña A, Casanova M, Breña Atienza J, Garcia A, de Arriba F, Martínez-Chamorro C, Sirvent M, Blanchard MJ, Alonso Fernández R, Alvarez Rivas MA, Capote FJ, García-Sánchez R, Pérez JJ Sr, Rodriguez-Otero P, Lahuerta JJ, Martínez-López J, Mateos MV, San-Miguel JF.
Real-world evidence of measurable residual disease assessment in multiple myeloma.
Blood Advances . 10(5): 1559-1563.
-
Martin-Moro F, Bento L, Marquet J, Browne-Arthur SF, Gutierrez A, Diaz-Lopez A, Sanchez-Pina J, Garcia-Vela JA, Salar A, Cordoba R, Novelli S, Rodriguez-Salazar MJ, Gonzalez De Villambrosia S, Del Campo R, Luzardo HD, Garcia D, Garcia-Marco JA, Sancho JM, Abrisqueta P, Martin A, Grande C, Lopez-Jimenez J, Bastos-Oreiro M.
Laboratory Prognostic Index (LAB-PI) in diffuse large B-cell lymphoma: a single blood analysis predicts outcomes as good as IPI, NCCN-IPI, and GELTAMO-IPI
ESMO open . 10(12): 105873-105873.
-
Luttwak E, Nemirovsky D, Devlin SM, Boardman AP, Cassanello G, Corona M, Luan D, Dahi PB, Abia AL, Falchi L, Landego I, Lin RJ, Lue JK, Palomba LM, Park JH, Raj SS, Rejeski K, Rivas Delgado A, Scordo M, Tomas AA, Shah GL, Perales MA, Salles G, Shouval R.
Patterns and safety of glucocorticosteroid use following CD19 CAR-T therapy for large B-cell lymphoma
Hemasphere . 9(11): .
-
Deschênes-Simard X, Bromberg M, Devlin SM, Gonen M, Beyar-Katz O, Ip A, Marcus R, Avigdor A, Ballweg A, Rabinovich E, Alhomoud M, Rivas-Delgado A, Corona De Lapuerta M, Luna De Abia A, Palomba ML, Shah GL, Lin RJ, Boardman AP, Falchi L, Lue JK, Salles GA, Perales MA, Shouval R, Dahi PB, Scordo M.
Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphoma
Blood Advances . 9(21): 5571-5584. Number of citations: 1
-
Corona M, Brown S, Rejeski K, Flynn JR, Devlin SM, Raj S, Luna de Abia A, Lin RJ, Scordo M, Shah GL, Palomba ML, Boardman AP, Falchi L, Lue J, Salles G, Park J, Giralt SA, Perales MA, Shouval R, Dahi PB.
Late hematologic toxicity after CAR T-cell therapy in large B-cell lymphoma: incidence, risk factors, and clinical impact
BONE MARROW TRANSPLANTATION . 61(2): 142-148.
-
Sobrini-Morillo P, Corral-Tuesta C, Sánchez-Castellano C, Gutiérrez-Blanco T, Blanchard-Rodríguez MJ, Escudero-González B, Nieto-Góngora C, Moujir López J, Serra-Rexach JA, Cruz-Jentoft AJ.
Sarcopenia in Older Patients with Newly Diagnosed Multiple Myeloma
Gerontology . 72(1): 1-10.
-
Alfonso-Pierola A, Martinez-Cuadrón D, Rodríguez-Veiga R, Gil C, Martínez-Sánchez P, Bernal T, Benavente C, Romero-Riquelme MA, Serrano-Lopez J, Bergua JM, García-Boyero R, Tormo M, Herrera P, Sossa-Melo CL, Pérez-Simon JA, Rodríguez-Medina C, Bass-Maturana MF, López-Lorenzo JL, Algarra-Algarra L, Vidriales-Vicente B, Pérez-Encinas M, Barrios-García M, Vives S, Sayas-Lloris MJ, Capurro M, Hidalgo S, Olave M, Cuervo-Lozada D, Lavilla-Rubira E, Casado F, Mena-Durán A, Valero-Nuñez M, Casado-Calderón S, Balerdi A, Torres V, Fernández R, Noriega V, Stevenazzi M, Labrador J, León-Maldonado P, de Rueda-Ciller B, Arce-Fernández O, Amigo ML, Raposo-Puglia JÁ, Solé M, Boluda B, Ayala R, Barragán E, Montesinos P.
Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registry
Leukemia . 39(11): 2686-2696.
-
Lahuerta JJ, San-Miguel JF, Jiménez-Ubieto A, Alonso Fernández R, Paiva B, Puig N, Cedena MT, Gutierrez NC, Calasanz MJ, Fernandez M, Ríos-Tamayo R, Oriol A, Blanchard MJ, Carrillo-Cruz E, Martínez-Martínez R, Bargay J, Sureda A, de la Rubia J, Hernandez Garcia MT, Cabañas V, Casado Montero LF, Palomera Bernal L, Gonzalez-Montes Y, Martínez-López J, Rodriguez-Otero P, Krsnik I, Arguiñano JM, Gonzalez-Garcia ME, Ocio EM, de la Cruz J, Mateos MV, Rosiñol L, Bladé J.
High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial
Blood . 146(15): 1747-1758. Number of citations: 2
-
Asensi-Díaz E, Barbero Del Olmo L, Urrutia P, Lario A, Gómez-G de la Pedrosa E, García-Ruiz de Morales AG, Martín-Dávila P, Fortún J.
When Fungal Prophylaxis Fails: A Rare Case of Rhodotorula mucilaginosa Fungemia with Suspected Abdominal Origin
JOURNAL OF FUNGI . 11(10): . Number of citations: 1
-
Encinas C, Blanchard MJ, Fernández RA, Hernández-Rivas JÁ, Tamayo RR, Machado-Vílchez M, Martínez-López J, Mateos MV.
Factors Increasing the Risk of Infection in Patients With Multiple Myeloma: From Biology to Prevention
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA . 25(10): .
-
Mataix M, Illera N, Hidalgo I, Arriba MDC, Martín E, Fernández G, González C, Larcher F, González VM, Rio MD, Jiménez F, Carretero M.
Targeting olfactory receptor OR2AT4: An innovative aptamer-based treatment for hair growth promotion
MOLECULAR THERAPY NUCLEIC ACIDS . 36(3): 102608-102608.
-
Sobrini-Morillo P, Corral-Tuesta C, Sánchez-Castellano C, Gutiérrez-Blanco T, Palomo-Rumschisky P, Álvarez-Pinheiro CG, Blanchard-Rodríguez MJ, Serra-Rexach JA, Cruz-Jentoft AJ.
Comprehensive Geriatric Assessment of Older Patients with Multiple Myeloma: A Prospective Observational Study
Cancers . 17(17): .